Clinical Trials Browser

Phase 2 × sulforaphane × Genitourinary × Clear all

NCT01228084 2017-04-28

Sulforaphane in Treating Patients With Recurrent Prostate Cancer

Phase 2 Completed

20 enrolled 11 charts

Prostatic Neoplasms